We are live on ! Find out more
Sarah Ketterer

Sarah Ketterer Causeway Capital Management

AUM $8.9B Turnover 35.42%
1-Year Est. Return 6.03%
 

Sarah Ketterer is co-founder and CEO of Causeway Capital Management, a firm specializing in international and global value equities. Causeway is known for disciplined valuation work across developed and emerging markets. Ketterer’s commentary is often sought for perspective on non-U.S. equities, currencies, and relative value abroad.

This Fund
S&P 500
This Quarter Est. Return
-2.97%
1 Year Est. Return
+6.03%
3 Year Est. Return
+72.18%
5 Year Est. Return
+74.16%
10 Year Est. Return
+232.95%
AUM
$8.9B
AUM Growth
-$336M
Cap. Flow
+$158M
Cap. Flow %
1.77%
Top 10 Hldgs %
69.42%
Holding
144
New
22
Increased
20
Reduced
67
Closed
29
Avg Time Held
2.5 years
Top 10 Avg Time Held
1.1 years
Top 20 Avg Time Held
1.3 years

Top Buys

Rank Stock Value
1
SE icon
Sea Limited
SE
+$1.01B
2
AZN icon
AstraZeneca
AZN
+$278M
3
PBR.A icon
Petrobras Class A
PBR.A
+$74.7M
4
FXI icon
iShares China Large-Cap ETF
FXI
+$61M
5
CDW icon
CDW
CDW
+$57.7M

Top Sells

Rank Stock Value
1
CCL icon
Carnival
CCL
+$184M
2
DB icon
Deutsche Bank
DB
+$167M
3
SW icon
Smurfit Westrock
SW
+$104M
4
MRK icon
Merck
MRK
+$80.4M
5
BIIB icon
Biogen
BIIB
+$60.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 27.39%
2 Healthcare 24.89%
3 Financials 16.79%
4 Industrials 11.25%
5 Technology 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TRMD icon
101
TORM
TRMD
$3.31B
$431K ﹤0.01%
11,244
– –
2026 Q2
1 quarter
AAPL icon
102
Apple
AAPL
$5.07T
$296K ﹤0.01%
889
-58
-6% -$18.6K
2024 Q3
8 quarters
PDS icon
103
Precision Drilling
PDS
$1.11B
$266K ﹤0.01%
3,291
– –
2025 Q4
3 quarters
MSFT icon
104
Microsoft
MSFT
$3.7T
$262K ﹤0.01%
510
-90
-15% -$41.6K
2024 Q1
10 quarters
INMD icon
105
InMode
INMD
$731M
$258K ﹤0.01%
18,180
– –
2025 Q4
3 quarters
AVGO icon
106
Broadcom
AVGO
$1.65T
$245K ﹤0.01%
698
-104
-13% -$39.2K
2025 Q4
3 quarters
EFV icon
107
iShares MSCI EAFE Value ETF
EFV
$29.4B
$241K ﹤0.01%
+6,078
New +$245K
2026 Q3
0 quarters
FIX icon
108
Comfort Systems
FIX
$39B
$240K ﹤0.01%
145
-17
-10% -$28.5K
2025 Q4
3 quarters
RNR icon
109
RenaissanceRe
RNR
$13.9B
$239K ﹤0.01%
751
-243
-24% -$78.7K
2025 Q4
3 quarters
LRCX icon
110
Lam Research
LRCX
$255B
$232K ﹤0.01%
707
-109
-13% -$34K
2026 Q2
1 quarter
BMY icon
111
Bristol-Myers Squibb
BMY
$119B
$229K ﹤0.01%
+3,673
New +$232K
2026 Q3
0 quarters
ALL icon
112
Allstate
ALL
$66B
$216K ﹤0.01%
974
-133
-12% -$33.7K
2026 Q1
2 quarters
CCK icon
113
Crown Holdings
CCK
$12.8B
$214K ﹤0.01%
+2,031
New +$233K
2026 Q3
0 quarters
ADT icon
114
ADT
ADT
$7.22B
$174K ﹤0.01%
+28,666
New +$204K
2026 Q3
0 quarters
INN icon
115
Summit Hotel Properties
INN
$774M
$96.6K ﹤0.01%
16,180
-883
-5% -$5.51K
2025 Q2
5 quarters
ACWI icon
116
iShares MSCI ACWI ETF
ACWI
$30.9B
– –
-7,691
Closed -$1.21M –
AU icon
117
AngloGold Ashanti
AU
$38.9B
– –
-688,027
Closed -$55.7M –
BIIB icon
118
Biogen
BIIB
$36.5B
– –
-278,283
Closed -$60.1M –
BP icon
119
BP
BP
$111B
– –
-46,059
Closed -$1.7M –
BTG icon
120
B2Gold
BTG
$5.73B
– –
-94,491
Closed -$354K –
CNQ icon
121
Canadian Natural Resources
CNQ
$91B
– –
-18,400
Closed -$728K –
DIS icon
122
Walt Disney
DIS
$205B
– –
-360,600
Closed -$34.7M –
EEM icon
123
iShares MSCI Emerging Markets ETF
EEM
$26.3B
– –
-74,974
Closed -$5.13M –
G icon
124
Genpact
G
$6.83B
– –
-710,380
Closed -$19.5M –
GFI icon
125
Gold Fields
GFI
$28.9B
– –
-1,713,233
Closed -$57.5M –

Similar funds

Sarah Ketterer's Q3 2026 Portfolio in Review

As of Q3 2026, Sarah Ketterer held 144 positions worth $8.9B, down 3.6% from $9.24B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Sarah Ketterer's Q3 2026 filing shows 22 new, 20 increased, 67 reduced and 29 closed positions. Its largest new stake was Sea Limited: 9,185,637 shares worth $894M. The largest sale was Carnival, an estimated $184M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Sarah Ketterer's largest Q3 2026 buy was Sea Limited: 9,185,637 shares worth $894M.
  • Sarah Ketterer added most to AstraZeneca in Q3 2026, an estimated $278M increase.
  • Sarah Ketterer's biggest Q3 2026 reduction was Carnival, cutting an estimated $184M.
  • Sarah Ketterer fully exited Biogen in Q3 2026, selling an estimated $60.1M.
  • Sarah Ketterer's ten largest holdings make up 69% of its $8.9B portfolio in Q3 2026.
  • Sarah Ketterer opened 22 new positions and closed 29 in Q3 2026.
  • Sarah Ketterer's portfolio value fell 3.6% quarter-over-quarter to $8.9B.

Based on Causeway Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.